|
U2AF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.908000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.430600E-01 |
| Normal-vs-Stage2 |
2.410800E-01 |
| Normal-vs-Stage3 |
1.958030E-01 |
| Normal-vs-Stage4 |
9.953000E-01 |
| Stage1-vs-Stage2 |
1.410350E-01 |
| Stage1-vs-Stage3 |
1.035970E-01 |
| Stage1-vs-Stage4 |
8.138800E-01 |
| Stage2-vs-Stage3 |
9.496200E-01 |
| Stage2-vs-Stage4 |
2.062600E-01 |
| Stage3-vs-Stage4 |
1.626210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.392000E-01 |
| Normal-vs-AfricanAmerican |
1.623850E-01 |
| Normal-vs-Asian |
1.782160E-01 |
| Caucasian-vs-AfricanAmerican |
2.077400E-03 |
| Caucasian-vs-Asian |
3.720400E-02 |
| AfricanAmerican-vs-Asian |
5.052800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.616820E-01 |
| Normal-vs-Female |
4.997600E-01 |
| Male-vs-Female |
1.738980E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.676200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.191600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.694800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.209500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.151000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.663400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.266990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.574200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.498000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.897600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.169400E-04 |
| Normal-vs-Grade 2 |
5.805400E-01 |
| Normal-vs-Grade 3 |
2.060800E-01 |
| Normal-vs-Grade 4 |
9.326000E-01 |
| Grade 1-vs-Grade 2 |
6.382100E-04 |
| Grade 1-vs-Grade 3 |
2.442300E-04 |
| Grade 1-vs-Grade 4 |
3.787300E-04 |
| Grade 2-vs-Grade 3 |
2.650400E-01 |
| Grade 2-vs-Grade 4 |
6.523800E-01 |
| Grade 3-vs-Grade 4 |
2.346400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.561200E-01 |
| Normal-vs-ccB subtype |
1.971370E-01 |
| ccA subtype-vs-ccB subtype |
4.993600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.230800E-01 |
| Normal-vs-N1 |
3.881000E-01 |
| N0-vs-N1 |
6.659600E-01 |
|
|
